| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |